Influence of tumor response and treatment schedule on the distribution of tumor recurrence in esophageal cancer patients treated with neoadjuvant chemoradiotherapy-Reference-Cited by-同舟云学术

Influence of tumor response and treatment schedule on the distribution of tumor recurrence in esophageal cancer patients treated with neoadjuvant chemoradiotherapy

Published:2017-08-29 Issue:8 Volume:116 Page:1096-1102
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Jipping Kristien M.¹,Hulshoff Jan Binne¹^ORCID,van Amerongen Evita A.¹,Bright Tim I.²,Watson David I.²,Plukker John Th.M.¹

Affiliation:

1. Department of Surgical Oncology, University of Groningen; University Medical Center Groningen; Groningen The Netherlands

2. Department of Surgery, Flinders University, Flinders Medical Centre; Flinders Medical Centre; Bedford Park South Australia Australia

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference23 articles.

1. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

2. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015

3. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer;Geh;Br J Surg,2001

4. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response;Blackham;J Surg Oncol,2015

5. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer;Reynolds;Ann Surg,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Commentary: Making the grade: Prognostic, therapeutic, and staging implications of tumor differentiation in esophageal adenocarcinoma;The Journal of Thoracic and Cardiovascular Surgery;2023-10

2. Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis;Current Oncology;2022-09-16

3. Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy;Annals of Surgical Oncology;2020-10-19

4. Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus;Annals of Surgery;2019-12-17

5. Recurrence in complete responders after trimodality therapy in esophageal cancer;Journal of Thoracic Disease;2019-05